Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 9,890.00
-80.00 (-0.80%)
Nov 2, 2026, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 242.75 billion as of October 30, 2026. It is the 21,234th most valuable company in the world and the 712th biggest in South Korea. Its market cap has decreased by 51.98% in one year.
Market Cap
242.75B
Enterprise Value
163.90B
Revenue
2.95B
Global Rank
Country Rank
#712 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 242.75B, an increase of 311.45%. That is a compound annual growth rate of 15.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 242.75B | -63.19% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medy-Tox | 412.68B |
| AbClon | 368.52B |
| Orum Therapeutics | 333.25B |
| MEDIPOST | 316.20B |
| SillaJen | 279.88B |
| HLB Therapeutics | 219.91B |
| GC Genome | 215.22B |
| Bioneer | 175.77B |